Home Research COVID-19 Services Publications People Teaching Job Opening News Forum Lab Only
Online Services

●I-TASSER ●I-TASSER-MTD ●C-I-TASSER ●CR-I-TASSER ●QUARK ●C-QUARK ●LOMETS ●MUSTER ●CEthreader ●SEGMER ●DeepFold ●DeepFoldRNA ●FoldDesign ●COFACTOR ●COACH ●MetaGO ●TripletGO ●IonCom ●FG-MD ●ModRefiner ●REMO ●DEMO ●DEMO-EM ●SPRING ●COTH ●Threpp ●PEPPI ●BSpred ●ANGLOR ●EDock ●BSP-SLIM ●SAXSTER ●FUpred ●ThreaDom ●ThreaDomEx ●EvoDesign ●BindProf ●BindProfX ●SSIPe ●GPCR-I-TASSER ●MAGELLAN ●ResQ ●STRUM ●DAMpred

●TM-score ●TM-align ●US-align ●MM-align ●RNA-align ●NW-align ●LS-align ●EDTSurf ●MVP ●MVP-Fit ●SPICKER ●HAAD ●PSSpred ●3DRobot ●MR-REX ●I-TASSER-MR ●SVMSEQ ●NeBcon ●ResPRE ●TripletRes ●DeepPotential ●WDL-RF ●ATPbind ●DockRMSD ●DeepMSA ●FASPR ●EM-Refiner ●GPU-I-TASSER

●BioLiP ●E. coli ●GLASS ●GPCR-HGmod ●GPCR-RD ●GPCR-EXP ●Tara-3D ●TM-fold ●DECOYS ●POTENTIAL ●RW/RWplus ●EvoEF ●HPSF ●THE-DB ●ADDRESS ●Alpaca-Antibody ●CASP7 ●CASP8 ●CASP9 ●CASP10 ●CASP11 ●CASP12 ●CASP13 ●CASP14

BioLiP
Download all results in tab-seperated text for 44 receptor-ligand interactions, whose format is explained at readme.txt.
  • Hover over PDB to view the title of the structure. Click PDB to view the structure at the RCSB PDB database. Resolution -1.00 means the resolution is unavailable, e.g., for NMR structures.
  • Click Site # to view the binding site structure. Hover over Site # to view the binding residues.
  • Hover over Ligand to view the full ligand name. Click Ligand to view the 2D diagram and other detail information of the ligand.
  • Hover over EC number to view the full name of enzymatic activity.
  • Hover over GO terms to view all GO terms.
  • Hover over UniProt to view the protein name.

    • Sort results by
    << < 1 > >>
    Go to page

    # PDB
    (Resolution Å)     		Site # Ligand EC number GO terms UniProt PubMed Binding
    affinity
    1 8ari:A (3.0) BS01 peptide 1.1.1.- GO:0000122 ... Q13363 N/A
    2 8ari:A (3.0) BS02 NAD 1.1.1.- GO:0000122 ... Q13363 N/A
    3 8ari:B (3.0) BS01 NAD 1.1.1.- GO:0000122 ... Q13363 N/A
    4 8ari:C (3.0) BS01 NAD 1.1.1.- GO:0000122 ... Q13363 N/A
    5 8ari:D (3.0) BS01 peptide 1.1.1.- GO:0000122 ... Q13363 N/A
    6 8ari:D (3.0) BS02 NAD 1.1.1.- GO:0000122 ... Q13363 N/A
    7 8ari:E (3.0) BS01 peptide 1.1.1.- GO:0000122 ... Q13363 N/A
    8 8ari:E (3.0) BS02 NAD 1.1.1.- GO:0000122 ... Q13363 N/A
    9 8ari:F (3.0) BS01 peptide 1.1.1.- GO:0000122 ... Q13363 N/A
    10 8ari:F (3.0) BS02 NAD 1.1.1.- GO:0000122 ... Q13363 N/A
    11 8ari:G (3.0) BS01 peptide 1.1.1.- GO:0000122 ... Q13363 N/A
    12 8ari:G (3.0) BS02 NAD 1.1.1.- GO:0000122 ... Q13363 N/A
    13 8ari:H (3.0) BS01 peptide 1.1.1.- GO:0000122 ... Q13363 N/A
    14 8ari:H (3.0) BS02 NAD 1.1.1.- GO:0000122 ... Q13363 N/A
    15 8ari:I (3.0) BS01 peptide 1.1.1.- GO:0000122 ... Q13363 N/A
    16 8ari:I (3.0) BS02 NAD 1.1.1.- GO:0000122 ... Q13363 N/A
    17 8ari:J (3.0) BS01 peptide 1.1.1.- GO:0000122 ... Q13363 N/A
    18 8ari:J (3.0) BS02 NAD 1.1.1.- GO:0000122 ... Q13363 N/A
    19 8ari:K (3.0) BS01 peptide 1.1.1.- GO:0000122 ... Q13363 N/A
    20 8ari:K (3.0) BS02 NAD 1.1.1.- GO:0000122 ... Q13363 N/A
    21 8ari:L (3.0) BS01 peptide 1.1.1.- GO:0000122 ... Q13363 N/A
    22 8ari:L (3.0) BS02 NAD 1.1.1.- GO:0000122 ... Q13363 N/A
    23 8ari:M (3.0) BS01 peptide 1.1.1.- GO:0000122 ... Q13363 N/A
    24 8ari:M (3.0) BS02 NAD 1.1.1.- GO:0000122 ... Q13363 N/A
    25 8ari:N (3.0) BS01 peptide 1.1.1.- GO:0000122 ... Q13363 N/A
    26 8ari:N (3.0) BS02 NAD 1.1.1.- GO:0000122 ... Q13363 N/A
    27 8ari:O (3.0) BS01 peptide 1.1.1.- GO:0000122 ... Q13363 N/A
    28 8ari:O (3.0) BS02 NAD 1.1.1.- GO:0000122 ... Q13363 N/A
    29 8ari:P (3.0) BS01 peptide 1.1.1.- GO:0000122 ... Q13363 N/A
    30 8ari:P (3.0) BS02 NAD 1.1.1.- GO:0000122 ... Q13363 N/A
    31 8ari:Q (3.0) BS01 peptide 1.1.1.- GO:0000122 ... Q13363 N/A
    32 8ari:Q (3.0) BS02 NAD 1.1.1.- GO:0000122 ... Q13363 N/A
    33 8ari:R (3.0) BS01 peptide 1.1.1.- GO:0000122 ... Q13363 N/A
    34 8ari:R (3.0) BS02 NAD 1.1.1.- GO:0000122 ... Q13363 N/A
    35 8ari:S (3.0) BS01 peptide 1.1.1.- GO:0000122 ... Q13363 N/A
    36 8ari:S (3.0) BS02 NAD 1.1.1.- GO:0000122 ... Q13363 N/A
    37 8ari:T (3.0) BS01 peptide 1.1.1.- GO:0000122 ... Q13363 N/A
    38 8ari:T (3.0) BS02 NAD 1.1.1.- GO:0000122 ... Q13363 N/A
    39 8ari:U (3.0) BS01 peptide 1.1.1.- GO:0000122 ... Q13363 N/A
    40 8ari:U (3.0) BS02 NAD 1.1.1.- GO:0000122 ... Q13363 N/A
    41 8ari:V (3.0) BS01 NAD 1.1.1.- GO:0000122 ... Q13363 N/A
    42 8ari:W (3.0) BS01 NAD 1.1.1.- GO:0000122 ... Q13363 N/A
    43 8ari:X (3.0) BS01 peptide 1.1.1.- GO:0000122 ... Q13363 N/A
    44 8ari:X (3.0) BS02 NAD 1.1.1.- GO:0000122 ... Q13363 N/A
    Reference:
  • Chengxin Zhang, Xi Zhang, Peter L Freddolino, and Yang Zhang. BioLiP2: an updated structure database for biologically relevent ligand-protein interactions, Nucleic Acids Research, gkad630 (2023)(download the PDF file).
  • Jianyi Yang, Ambrish Roy, and Yang Zhang. BioLiP: a semi-manually curated database for biologically relevant ligand-protein interactions, Nucleic Acids Research, 41: D1096-D1103 (2013) (download the PDF file).

    • zhanglabzhanggroup.org | +65-6601-1241 | Computing 1, 13 Computing Drive, Singapore 117417